Skip to content
Disclosery

EXANE DERIVATIVES: PWR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PWR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,609 PWR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,609 shares
    Change vs previous 13F -984 shares

    0.26% of the 13F portfolio, value $452,260.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,593 shares
    Change vs previous 13F -1,055 shares

    0.17% of the 13F portfolio, value $604,447.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,648 shares
    Change vs previous 13F +386 shares

    0.16% of the 13F portfolio, value $647,576.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5,262 shares
    Change vs previous 13F -3,094 shares

    0.15% of the 13F portfolio, value $598,899.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 8,356 shares
    Change vs previous 13F +6,951 shares

    0.18% of the 13F portfolio, value $749,850.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,405 shares
    Change vs previous 13F +633 shares

    0.04% of the 13F portfolio, value $123,606.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 772 shares
    Change vs previous 13F +310 shares

    0.02% of the 13F portfolio, value $55,597.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 462 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $24,420.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).